Alector (ALEC) Net Margin Growth (3y) (2021 - 2026)

Alector (ALEC) Net Margin Growth (3y) (2021 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin Growth (3y) (Qtr)
1 Oculis Holding AG 66,320.50 Bn 66,320.21 Bn - -
2 Nanobiotix 1,933.82 Bn 1,933.76 Bn - -
3 Akari Therapeutics 1,022.34 Bn 1,022.34 Bn - -
4 BeOne Medicines 472.93 Bn 468.14 Bn 1.35 Bn 9,283.00
5 Vertex Pharmaceuticals 122.22 Bn 114.98 Bn 2.59 Bn 506.00
6 Regeneron Pharmaceuticals 69.96 Bn 61.21 Bn 3.31 Bn -569.00
7 Belite Bio 62.66 Bn 62.66 Bn - -
8 Argenx Se 56.07 Bn 50.89 Bn 1.41 Bn 6,537.00
9 Alnylam Pharmaceuticals 37.60 Bn 34.59 Bn 959.66 Mn 7,218.00
10 Alector 168.65 Mn -37.87 Mn - -191,506.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -191,506.00
Dec 31, 2025 -23,175.00
Sep 30, 2025 -75,269.00
Jun 30, 2025 -40,003.00
Mar 31, 2025 -91,925.00
Dec 31, 2024 33,904.00
Sep 30, 2024 -34,459.00
Jun 30, 2024 58,321.00
Mar 31, 2024 104,236.00
Dec 31, 2023 301,977.00
Sep 30, 2023 53,056.00
Jun 30, 2023 447,327.00
Mar 31, 2023 164,244.00
Dec 31, 2022 17,587.00
Sep 30, 2022 365,653.00
Jun 30, 2022 112,189.00
Mar 31, 2022 106,976.00
Dec 31, 2021 -13,492.00
Sep 30, 2021 32,797.00
Jun 30, 2021 -66,758.00